Varga L - Search Results

1

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma.

Maráz A, Cserháti A, Uhercsák G, Szilágyi É, Varga Z, Révész J, Kószó R, Varga L, Kahán Z. Maráz A, et al. Among authors: varga l, varga z. BMC Cancer. 2018 Mar 15;18(1):296. doi: 10.1186/s12885-018-4209-9. BMC Cancer. 2018. PMID: 29544452 Free PMC article.

2

The Colorful Palette of Neuroendocrine Neoplasms in the Genitourinary Tract.

Pósfai B, Kuthi L, Varga L, Laczó I, Révész J, Kránicz R, Maráz A. Pósfai B, et al. Among authors: varga l. Anticancer Res. 2018 Jun;38(6):3243-3254. doi: 10.21873/anticanres.12589. Anticancer Res. 2018. PMID: 29848671 Free article. Review.

3

Daily Setup Accuracy, Side-effects and Quality of Life During and After Prone Positioned Prostate Radiotherapy.

Varga L, Kószó RL, Fodor E, Cserháti A, Varga Z, Darázs B, Kahán Z, Hideghéty K, Borzási E, Szabó D, Müllner K, Maráz A. Varga L, et al. Among authors: varga z. Anticancer Res. 2018 Jun;38(6):3699-3705. doi: 10.21873/anticanres.12648. Anticancer Res. 2018. PMID: 29848730 Free article.

4

Prone Positioning on a Belly Board Decreases Rectal and Bowel Doses in Pelvic Intensity-Modulated Radiation Therapy (IMRT) for Prostate Cancer.

Kószó R, Varga L, Fodor E, Kahán Z, Cserháti A, Hideghéty K, Együd Z, Szabó C, Borzási E, Szabó D, Müllner K, Varga Z, Maráz A. Kószó R, et al. Among authors: varga l, varga z. Pathol Oncol Res. 2019 Jul;25(3):995-1002. doi: 10.1007/s12253-018-0436-2. Epub 2018 Jun 7. Pathol Oncol Res. 2019. PMID: 29882196 Free article.

5

[Edifications and modern strategies of localized prostate cancers' definitive therapy].

Varga L, Bajory Z, Pajor L, Révész J, Sükösd F, Maráz A. Varga L, et al. Orv Hetil. 2018 Aug;159(32):1317-1325. doi: 10.1556/650.2018.31105. Orv Hetil. 2018. PMID: 30078360 Hungarian.

6

ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer.

Küronya Z, Sükösd F, Varga L, Bíró K, Gyergyay F, Géczi L, Nagyiványi K, Jorgo K, Szarvas T, Kovács Á, Laczó I, Varga Z, Pósfai B, Pepó J, Maráz A. Küronya Z, et al. Among authors: varga l, varga z. Urol Oncol. 2019 Apr;37(4):289.e1-289.e9. doi: 10.1016/j.urolonc.2018.12.007. Epub 2019 Jan 21. Urol Oncol. 2019. PMID: 30679082

7

[Opportunities that improve the effectivity of immunotherapy, bringing targeted therapies into focus].

Maráz A, Varga L, Küronya Z. Maráz A, et al. Among authors: varga l. Magy Onkol. 2019 Sep 18;63(3):209-216. Epub 2019 Aug 13. Magy Onkol. 2019. PMID: 31533141 Free article. Review. Hungarian.

8

[Therapeutic sequences in the treatment of advanced/metastatic prostate cancer].

Maráz A, Géczi L, Biró K, Varga L, Küronya Z. Maráz A, et al. Among authors: varga l. Magy Onkol. 2020 Sep 23;64(3):263-272. Epub 2020 Aug 31. Magy Onkol. 2020. PMID: 32966355 Free article. Hungarian.

9

[New aspects of chemotherapy and indications for maintenance immunotherapy in urothelial cancers].

Maráz A, Varga L, Pósfai B, Géczi L, Küronya Z. Maráz A, et al. Among authors: varga l. Magy Onkol. 2021 Dec 7;65(4):329-337. Epub 2021 Oct 20. Magy Onkol. 2021. PMID: 34874364 Free article. Hungarian.

10

Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data.

Revesz J, Posfai B, Pajor L, Papdan T, Varga L, Paczona VR, Varga Z, Sukosd F, Maraz A. Revesz J, et al. Among authors: varga l, varga z. Pathol Oncol Res. 2023 Apr 21;29:1611077. doi: 10.3389/pore.2023.1611077. eCollection 2023. Pathol Oncol Res. 2023. PMID: 37151354 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters